C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients
Acta Biochimica Polonica · 27.11.2020
DOI: 10.18388/abp.2020_5402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Polonica, online erschienen am 27.11.2020. Verfasst von Emilia Dąbrowska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Esthetic Medicine, Medical University of Bialystok, Białystok, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
The chemokine CCL5 and its receptor CCR5 play important roles in cancer invasion and metastasis. Based on our knowledge, our results were the first that presented the diagnostic usefulness of CCL5 and CCR5 in breast cancer (BC) patients, based on receiver operating characteristic (ROC) curve analysis. We wished to examine further if CCL5 and CCR5 are appropriate to be applied as BC markers for early screening. Values of tested parameters in patients’ plasma were determined by CMIA method (Chemiluminescent Microparticle Immunoassay, CA 15-3) as well as by ELISA method (Enzyme-Linked Immunosorbent Assay, CCL5 and CCR5). Levels of CCL5 in the plasma were markedly increased, while those of CCR5 were remarkably lower in BC patients when compared to the control groups. Moreover, higher levels of CCL5 in BC corresponded to advanced tumor stage, while the levels of CCR5 decreased with increasing the disease stage. CCL5 concentration was characterized by high sensitivity (SE) (68.04%) and high specificity (SP) (100.00%) in the BC patients. Results indicated that area under the curve (AUC) corresponding to CCL5 (0.8116) had a higher value than this corresponding to CA 15-3. The AUC value of CCL5 was significantly increased in the early phase of BC (stage I – 0.7089; stage II – 0.8313). The maximum range in the BC patients was observed for the combined analysis of the tested measurands with CA 15-3 (0.8335). In conclusion, our research indicates that examination of plasma CCL5 and CCR5 may be useful in BC diagnosis at the early stage of the disorder, especially when combined with CA 15-3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Esthetic Medicine, Medical University of Bialystok, Białystok, Poland.
- Department of Biochemical Diagnostics, Medical University of Bialystok, Białystok, Poland.
- Department of Invasive Neurology, Medical University of Bialystok, Białystok, Poland.
- Department of Population Medicine and Civilization Diseases Prevention, Medical University of Bialystok, Białystok, Poland.
Zitieren
APA
Dąbrowska, E., Przylipiak, A., Zajkowska, M., Piskór, B. M., Borowik-Zaręba, A., & Ławicki, S. (2020). C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients. Acta Biochimica Polonica. https://doi.org/10.18388/abp.2020_5402
Vancouver
Dąbrowska E, Przylipiak A, Zajkowska M, Piskór BM, Borowik-Zaręba A, Ławicki S. C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients. Acta Biochimica Polonica. 2020. doi:10.18388/abp.2020_5402
BibTeX
@article{Dbrowska2020,
author = {Dąbrowska, Emilia and Przylipiak, Andrzej and Zajkowska, Monika and Piskór, Barbara Maria and Borowik-Zaręba, Aleksandra and Ławicki, Sławomir},
title = {C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients},
journal = {Acta Biochimica Polonica},
year = {2020},
doi = {10.18388/abp.2020_5402}
}
EUVIMED